Literature DB >> 20591244

Staged carotid stenting and carotid endarterectomy for bilateral internal carotid artery stenosis. Preliminary experience.

H Fukuda1, K Iihara, N Sakai, K Murao, H Sakai, T Higashi, S Kogure, J Takahashi, K Hayashi, I Nagata.   

Abstract

SUMMARY: The purpose of this study was to evaluate the efficacy and safety of staged carotid stenting (CS) and carotid endarterectomy (CEA) for bilateral internal carotid artery stenosis. With this strategy, initial carotid stenting was performed for the high grade carotid stenosis to reduce the risk of subsequent CEA. Eight patients were treated with staged CS and CEA; CS for asymptomatic side followed by CEA for symptomatic side. Sufficient revascularization was obtained in all procedures but one CS procedure. Two minor stroke caused by distal embolism occurred during the perioperative period of CS. Postprocedural persistent hypotension was observed in one CS procedure. The mean interval between CS and CEA was 19.8 days. In conclusion, although our strategy has some advantages such as avoidance of bilateral cranial nerve palsy and shorter admission period over staged CEA, relatively high complication rate was noted at the first CS without any stroke morbidity post CEA. Our preliminary result showed that further reduction of periprocedural complication rate at the initial stenting is mandatory for this approach justified.

Entities:  

Year:  2004        PMID: 20591244      PMCID: PMC3553470          DOI: 10.1177/15910199030090S120

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  10 in total

1.  Cerebrovascular hemodynamic changes associated with carotid endarterectomy.

Authors:  C T Araki; V L Babikian; N L Cantelmo; W C Johnson
Journal:  J Vasc Surg       Date:  1991-06       Impact factor: 4.268

2.  Angiographically defined collateral circulation and risk of stroke in patients with severe carotid artery stenosis. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group.

Authors:  R D Henderson; M Eliasziw; A J Fox; P M Rothwell; H J Barnett
Journal:  Stroke       Date:  2000-01       Impact factor: 7.914

3.  Stent angioplasty for cervical carotid artery stenosis in high-risk symptomatic NASCET-ineligible patients.

Authors:  A M Malek; R T Higashida; C C Phatouros; T E Lempert; P M Meyers; W S Smith; C F Dowd; V V Halbach
Journal:  Stroke       Date:  2000-12       Impact factor: 7.914

4.  Carotid artery angioplasty and use of stents in high-risk patients with contralateral occlusions.

Authors:  R A Mericle; S H Kim; G Lanzino; D K Lopes; A K Wakhloo; L R Guterman; L N Hopkins
Journal:  J Neurosurg       Date:  1999-06       Impact factor: 5.115

5.  Percutaneous transluminal angioplasty and stent placement for recurrent carotid artery stenosis.

Authors:  G Lanzino; R A Mericle; D K Lopes; A K Wakhloo; L R Guterman; L N Hopkins
Journal:  J Neurosurg       Date:  1999-04       Impact factor: 5.115

6.  Outcomes following extracranial carotid artery stenting in high-risk patients.

Authors:  D Paniagua; M Howell; N Strickman; J Velasco; K Dougherty; M Skolkin; B Toombs; Z Krajcer
Journal:  J Invasive Cardiol       Date:  2001-05       Impact factor: 2.022

7.  Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis.

Authors:  H J M Barnett; D W Taylor; R B Haynes; D L Sackett; S J Peerless; G G Ferguson; A J Fox; R N Rankin; V C Hachinski; D O Wiebers; M Eliasziw
Journal:  N Engl J Med       Date:  1991-08-15       Impact factor: 91.245

8.  Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study.

Authors: 
Journal:  JAMA       Date:  1995-05-10       Impact factor: 56.272

9.  Stenting in the carotid artery: initial experience in 110 patients.

Authors:  E B Diethrich; M Ndiaye; D B Reid
Journal:  J Endovasc Surg       Date:  1996-02

10.  Elective carotid artery stenting in the presence of contralateral occlusion.

Authors:  A Mathur; G S Roubin; C R Gomez; S S Iyer; P M Wong; C Piamsomboon; S S Yadav; L S Dean; J J Vitek
Journal:  Am J Cardiol       Date:  1998-06-01       Impact factor: 2.778

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.